Poland · Delayed Price · Currency is PLN Stem Cells Spin Statistics
Total Valuation
Stem Cells Spin has a market cap or net worth of PLN 16.53 million. The enterprise value is 16.69 million.
| Market Cap | 16.53M |
| Enterprise Value | 16.69M |
Important Dates
The last earnings date was Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Stem Cells Spin has 41.34 million shares outstanding.
| Current Share Class | 39.64M |
| Shares Outstanding | 41.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.39% |
| Owned by Institutions (%) | n/a |
| Float | 7.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 251.53 |
| PB Ratio | 2.59 |
| P/TBV Ratio | 2.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -32.22 |
| EV / Sales | 253.89 |
| EV / EBITDA | 16.52 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.70, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.70 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.79% and return on invested capital (ROIC) is -7.82%.
| Return on Equity (ROE) | -7.79% |
| Return on Assets (ROA) | -3.14% |
| Return on Invested Capital (ROIC) | -7.82% |
| Return on Capital Employed (ROCE) | -5.52% |
| Weighted Average Cost of Capital (WACC) | 6.54% |
| Revenue Per Employee | 65,736 |
| Profits Per Employee | -517,987 |
| Employee Count | 1 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.03 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +132.56% in the last 52 weeks. The beta is 0.43, so Stem Cells Spin's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +132.56% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.39 |
| Relative Strength Index (RSI) | 49.20 |
| Average Volume (20 Days) | 7,547 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Stem Cells Spin had revenue of PLN 65,736 and -517,987 in losses. Loss per share was -0.01.
| Revenue | 65,736 |
| Gross Profit | 49,335 |
| Operating Income | -517,425 |
| Pretax Income | -517,987 |
| Net Income | -517,987 |
| EBITDA | 1.01M |
| EBIT | -517,425 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 77,498 in cash and 232,704 in debt, with a net cash position of -155,206 or -0.00 per share.
| Cash & Cash Equivalents | 77,498 |
| Total Debt | 232,704 |
| Net Cash | -155,206 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 6.39M |
| Book Value Per Share | 0.15 |
| Working Capital | 531,246 |
Cash Flow
| Operating Cash Flow | -85,922 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.53M |
| Net Borrowing | 160,400 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 75.05% |
| Operating Margin | -787.13% |
| Pretax Margin | -787.98% |
| Profit Margin | n/a |
| EBITDA Margin | 1,536.55% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Stem Cells Spin does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.13% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |